Farms.com Home   Ag Industry News

Kroger Stops Selling Sprouts Due to Potential Health Risks

Supermarket Chain Takes Consumer Safety to a New Level

By , Farms.com

North American’s have heard a lot about recalled food this year – from millions of pounds of beef to thousands of jars of peanut butter – all recalled due to bacterial contamination, including E.coli and Salmonella.  Supermarket giant Kroger is taking consumer concerns one step further by discontinuing the sale of sprouts, which have been linked to as many as 2,500 illnesses in the U.S.A over the last two decades. 

“After a thorough, science-based review, we have decided to voluntarily discontinue selling fresh sprouts,” Payton Pruett, Kroger’s vice president of food safety, said in a statement. Kroger is not the only food retailer to end its relationship with sprout products. In 2010, Walmart discontinued the sale of raw sprouts in its stores - also due to potential health risks for their consumers.

“This is big,” Marion Nestle, a professor of food safety at New York University, told USA Today. “This is a major retailer saying ‘We aren’t going to take it anymore. We can’t risk harming our customers, and our suppliers are unwilling or unable to produce safe sprouts.’ “

This ban on sprouts includes Mung bean sprouts, which are often used for Chinese-style stir fry dishes and alfalfa sprouts, the tasty little threads that go well on sandwiches.


Trending Video

Finding a Balance of Innovation and Regulation - Dr. Peter Facchini

Video: Finding a Balance of Innovation and Regulation - Dr. Peter Facchini

Regulations help markets and industry exist on level playing fields, keeping consumers safe and innovation from going too far. However, incredibly strict regulations can stunt innovation and cause entire industries to wither away. Dr. Peter James Facchini brings his perspective on how existing regulations have slowed the advancement of medical developments within Canada. Given the international concern of opium poppy’s illicit potential, Health Canada must abide by this global policy. But with modern technology pushing the development of many pharmaceuticals to being grown via fermentation, is it time to reconsider the rules?

Dr. Peter James Facchini leads research into the metabolic biochemistry in opium poppy at the University of Calgary. For more than 30 years, his work has contributed to the increased availability of benzylisoquinoline alkaloid biosynthetic genes to assist in the creation of morphine for pharmaceutical use. Dr. Facchini completed his B.Sc. and Ph.D. in Biological Sciences at the University of Toronto before completing Postdoctoral Fellowships in Biochemistry at the University of Kentucky in 1992 & Université de Montréal in 1995.